Mass spectrometry (MS) is increasingly used in clinical medicine in Japan. In contrast to the successful application of MS in clinical microbiology, the adoption of MS-based assays for routine testing in clinical chemistry is very slow. In order to promote the significant benefits that MS platforms bring to laboratory medicine and patient care, the Japanese Society for Biomedical Mass Spectrometry (JSBMS) initiated a medical mass spectrometrist (MMS) certification program in 2013. As of Dec 2018, 308 persons from various medical specialties have been certified. We believe that they will play significant roles for expanding routine clinical MS usage in Japan.

质谱（MS）在日本的临床医学中越来越多地使用。与MS在临床微生物学中的成功应用相比，基于MS的测定法在临床化学中进行常规检测的速度非常慢。为了推广MS平台为实验室医学和患者护理带来的巨大利益，日本生物医学质谱学会（JSBMS）于2013年启动了医学质谱仪（MMS）认证计划。截至2018年12月，来自不同领域的308人医学专业已通过认证。我们相信，他们将在日本扩大常规临床MS使用方面发挥重要作用。